Research and Markets has announced the addition of Immunotherapy in Oncology: Drug Pipeline Update 2006 to their offering.

The immunotherapy field in cancer has never been more potent than it is right now, including block buster drugs like Avastin, Erbitux, and Rituxan. Antibodies are making the headlines but cancer vaccines are not far away. The recent approval of Gardasil, a cervical cancer vaccine, will certainly become a strong representative of its kind. Future challenges for the industry lie in discovering strong antigens, effective immunomodulators and developing suitable delivery technologies.

Today, there are more than 200 companies developing more than 340 immunotherapy drugs in more than 600 clinical trials targeting around 40 different cancer indications. Top five cancer indications in the field are: Melanoma, Breast, Lung, Prostate, and Colorectal.

Read more below how Immunotherapy in Oncology: Drug Pipeline Update is organized:.

Investigators Includes more than 200 principal researchers and a number of more collaborators.

Drug name & Synonyms Lists commercial, generic and code names for drugs. In several hundreds of synonym names.

Developmental stage Contains more than 340 drugs in development:.


Posted by: Andria    Source

---